Practical management of toxicities associated with bosutinib in patients with Philadelphia chromosome-positive chronic myeloid leukemia

類似資料

• Safety and efficacy of bosutinib (SKI-606) in chronic phase Philadelphia chromosome–positive chronic myeloid leukemia patients with resistance or intolerance to imatinib
  著者:: Cortes, Jorge E., 等
  出版事項: (2011)
• Long-term evaluation of cardiac and vascular toxicity in patients with Philadelphia chromosome-positive leukemias treated with bosutinib
  著者:: Cortes, Jorge E., 等
  出版事項: (2016)
• Bosutinib for the Treatment of Philadelphia Chromosome-Positive Leukemias
  著者:: Varallo-Rodriguez, Cristina, 等
  出版事項: (2015)
• Bosutinib in the treatment of patients with Philadelphia chromosome-positive (Ph+) chronic myelogenous leukemia: an overview
  著者:: Shen, Ann Q., 等
  出版事項: (2014)
• Long‐term patient‐reported outcomes from an open‐label safety and efficacy study of bosutinib in Philadelphia chromosome–positive chronic myeloid leukemia patients resistant or intolerant to prior therapy
  著者:: Kantarjian, Hagop M., 等
  出版事項: (2017)